Xoma Royalty and Lava Therapeutics…
Xoma Royalty and Lava Therapeutics are turning the temperature down, [...]
For the second year running,…
For the second year running, Pfizer has arrived at the [...]
Danish vaccine developer Evaxion…
Danish vaccine developer Evaxion has released long-term data for its [...]
Roche’s giredestrant was shown…
Roche’s giredestrant was shown to reduce the risk of breast [...]
For the second time, Astellas is…
For the second time, Astellas is walking away from Taysha [...]
Gilead’s Kite Pharma is doubling…
Gilead’s Kite Pharma is doubling down on in vivo CAR-T, [...]
The trials demonstrated the…
The trials demonstrated the benefits of Praxis’ ulixacaltamide in essential [...]
French antibody specialist…
French antibody specialist Adcytherix has added a €105 million ($122 [...]
Boehringer Ingelheim will pay…
Boehringer Ingelheim will pay AimedBio up to $991 million to [...]
Eli Lilly has guided its oral…
Eli Lilly has guided its oral GLP-1 drug candidate orforglipron [...]